Institutional Ownership
Allogene Therapeutics Inc
CUSIP 019770106COMALLOQ1 2026
Institutional Holders
203
13F filers
Shares Held
174.28M
Aggregate institutional
Institutional Value
$404.96M
Q1 2026
Net New Holders
+32
44 new · 12 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions44
Increased80
Decreased40
Sold out12
Institutional Holders
203 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Pfizer Inc | 22.03M | $49.79M | 0 | Held |
| 2 | Blackrock, Inc. | 19.09M | $46.58M | +1.42M | Added |
| 3 | Tpg Gp A, LLC | 18.72M | $45.67M | 0 | Held |
| 4 | State Street Corp | 8.66M | $21.13M | +5.90M | Added |
| 5 | Primecap Management Co/Ca/ | 8.38M | $20.45M | +240.0K | Added |
| 6 | Citadel Advisors LLC | 6.79M | $16.58M | −5.32M | Reduced |
| 7 | Two Sigma Investments, LP | 5.38M | $13.12M | +1.95M | Added |
| 8 | Geode Capital Management, LLC | 4.12M | $10.07M | +191.3K | Added |
| 9 | Frazier Life Sciences Management, L.P. | 3.80M | $9.26M | −72.1K | Reduced |
| 10 | Woodline Partners LP | 3.50M | $8.54M | +579 | Added |
193 more institutional holders on Premium
See every fund holding Allogene Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders